| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses and other current assets | 1,721 | |||
| Cash and cash equivalents | 31,942 | |||
| Total current assets | 33,663 | |||
| Property and equipment, net | 657 | |||
| Right-of-use assets | 1,507 | |||
| Other long-term assets | 226 | |||
| Total assets | 36,053 | |||
| Long-term debt, net of current portion | 18,786 | |||
| Long-term lease liabilities | 1,227 | |||
| Long-term contingent consideration | 3,230 | |||
| Total long-term liabilities | 23,243 | |||
| Accrued expenses and other current liabilities | 3,838 | |||
| Current portion of lease liabilities | 406 | |||
| Current portion of long-term debt | 9,511 | |||
| Current portion of contingent consideration | 1,603 | |||
| Accounts payable | 658 | |||
| Total current liabilities | 16,016 | |||
| Total liabilities | 39,259 | |||
| Accumulated deficit | -688,022 | |||
| Common stock, 0.001 par value 120,000,000 shares authorized as of september 30, 2024 and december 31, 2023 4,610,139 and 2,759,372 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively | 7 | |||
| Additional paid-in capital | 684,809 | |||
| Total stockholders' equity | -3,206 | |||
| Total liabilities and stockholders' equity | 36,053 | |||
KALA BIO, Inc. (KALA)
KALA BIO, Inc. (KALA)